Leptin administration is well-known to induce increases in blood pressure, and in hypertension associated with obesity, it has been long recognized that the cardiovascular responses to leptin are not reduced which is in stark contrast to the effects on dietary intake which were diminished compared to lean controls. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.